Annual Report 2021

China Merchants China Direct Investments Limited Annual Report 2021 36 INVESTMENT MANAGER’S DISCUSSION AND ANALYSIS (CONTINUED) SUB-PARTICIPATION SCHEME (CONTINUED) Name of projects Original investment amount of the Fund Original amounts actually paid by the Participants Relative proportion US$* US$* Iflytek Venture Capital (1st installment capital contribution) 5,193,900 9,270 0.178% Iflytek Venture Capital (2nd installment capital contribution) 2,008,800 3,480 0.178% Qinghai Lake Tourism (1st installment capital contribution) 7,502,800 9,590 0.128% Qinghai Lake Tourism (2nd installment capital contribution) 22,927,700 28,800 0.126% Iflytek Venture Capital (3rd installment capital contribution) 2,146,800 3,480 0.178% The Jiangmen Ventures Fund 4,741,800 20,470 0.432% Pony AI (1st round capital injection) 8,000,000 35,680 0.446% Iflytek Venture Capital (4th installment capital contribution) 1,991,910 3,480 0.178% Pony AI (2nd round capital injection) 607,270 10,200 1.680% Arashi Vision 4,268,200 26,820 0.632% iFlyHealth (1st round capital injection) 8,600,700 48,790 0.567% Iflytek Venture Capital (5th installment capital contribution) 646,170 1,160 0.178% China UnionPay 31,116,080 51,610 0.166% Iflytek Venture Capital (6th installment capital contribution) 1,286,760 2,320 0.178% CASREV Fund III (1st installment capital contribution) 1,849,360 2,580 0.140% CASREV Fund III (2nd installment capital contribution) 1,896,900 2,580 0.140% Huiyou Xingyao Fund (1st installment capital contribution) 2,469,420 14,900 0.603% Flexiv 5,000,000 95,450 1.909% Huashun Xin’an (1st installment capital contribution) 3,669,220 18,510 0.504% Huashun Xin’an (2nd installment capital contribution) 927,190 4,630 0.504% Huiyou Xingyao Fund (2nd installment capital contribution) 1,187,000 7,030 0.603% CASREV Fund III (3rd installment capital contribution) 1,931,490 2,580 0.140% Xinyi 5,416,700 23,150 0.427% iFlyHealth (2nd round capital injection) 7,804,570 19,250 0.247% Azuri 4,724,560 24,370 0.516% * Calculated with prevalent exchange rates at the time of the amounts paid